Dr Pinelopi Manousou is a Consultant Hepatologist at Imperial College Healthcare NHS Trust, and Honorary Senior Lecturer at Imperial College London. She leads the NAFLD service in the Trust, overseeing a clinic that cares for more than 600 patients. Her research interests are focused in translational aspects of NAFLD care, including prediction of cardiovascular risk, quantitation of liver biopsies from NAFLD patients using machine learning, and management of NAFLD cirrhosis.
Gil J, 2024, Detection of senescence using machine learning algorithms based on nuclear features, Nature Communications, ISSN:2041-1723
et al., 2024, Disruption of gut barrier integrity and host-microbiome interactions underlie MASLD severity in patients with type-2 diabetes mellitus, Gut Microbes, Vol:16, ISSN:1949-0976
et al., 2024, Translating the potential of the urine steroid metabolome to stage NAFLD (TrUSt-NAFLD): study protocol for a multicentre, prospective validation study., Bmj Open, Vol:14
et al., 2024, A prospective study on the prevalence of MASLD in people with type-2 diabetes in the community. Cost effectiveness of screening strategies, Liver International, Vol:44, ISSN:1478-3223, Pages:61-71
et al., 2024, Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients., J Hepatol, Vol:80, Pages:109-123